Report #2854773

Received Aug 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Aug 1, 2025
Onset: Aug 1, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Headache

Symptom narrative

Severe headache from Shingrix dose 2 yesterday; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 01-AUG-2025, the patient received the 2nd dose of Shingrix. In AUG-2025, an unknown time after receiving Shingrix, the patient experienced headache (Verbatim: Severe headache from Shingrix dose 2 yesterday). The outcome of the headache was not reported. The reporter considered the headache to be related to Shingrix. The company considered the headache to be related to Shingrix. Additional Information: GSK Receipt Date 02-AUG-2025 This case was reported by a patient via interactive digital media. The patient experienced severe headache from Shingrix dose 2 the day before reporting.